INTRODUCTION-Schizophrenia is an illness that may influence every aspect of the person's life. Rates of female sexual dysfunction (FSD) in schizophrenia the rates reported have been between 30 and 80%. The aim was to identify attribution (locus of control) and sexual dysfunction among female with schizophrenic disorder and females without schizophrenia and to study and to compare the sexual dysfunction and attribution in schizophrenic and non-schizophrenic women. METHODS-This was a cross sectional, hospital-based study and was approved by the Institutional Ethics Committee of SRM Medical college and health sciences. Women between the ages of 21 to 45 years, diagnosed with schizophrenia by ICD 10 criteria (World Health Organization, 1992) attending the outpatient services, who were under remission, and were in marital relationship for at least six months were approached for the study. Schizophrenia was assessed using PANSS while sexual dysfunction in females was assessed using female sexual functioning index. Sexual attribution was assessed by using Rotter's locus of control. RESULTS-45 women belonging to cases had sexual dysfunction as assessed by FSFI whilst 13 had had scored for sexual dysfunction is the control group. 5 in the cases and 37 in controls did not have sexual dysfunction. X 2 test was carried out and the difference was very highly statistically significant at 0.001level. A very high frequency of sexual dysfunction in this group calls for added focus in to this aspect for a better quality of life for the patient. The relationship between locus of control, sexual dysfunction as assessed by FSFI and PANSS scores where higher scores denote a severe form of illness were subjected to co-relation analysis. Locus of control is identified to be external when the scores are higher than the cut-off point. CONCLUSION-Sexual dysfunction is one of the aspects which affect the overall quality of life and needs to be studied on a larger sample and the relationship between illness related, treatment related and environment related factors need to be studied. Individual disturbances in the various aspects of sexual dysfunction also need to be studied.
Introduction: Treatment adherence and illness may not be related only by the severity of the illness but by so many other factors which impact on seeking and continuing treatment; yet severity of the illness will be one of the major factors influencing treatment adherence. Methods: Female patients attending the psychiatric OPD, diagnosed with depression as per ICD-10 guidelines and provided informed consent participated in this questionnaire-based study. A total of 135 patients who attended the OPD in 9 months were assessed for the severity of depression and medication adherence by administering scales to assess the severity of depression and medication adherence was assessed by questioning about the drug taking and hospital attending behaviour. Out of this, thirty-one were attending for the first episode and hence were excluded from the analysis. Results: Out of the 104 female patients diagnosed with depression of more than one episode, 44 (42.3%) had mild depression, 52 (50%) had moderate depression and 8 (7.7%) had severe depression. Twenty-nine women (27.9%) were on medications and 75 (72.1%) women were not taking their medications. While greater proportion of women with mild depression were adherent to medication (51.7%), more women with moderate depression didn’t adhere to medication (54.7%), even though such difference was statistically not significant. Older age, having a paid work and married status were significantly associated with medication (antidepressants) adherence. Conclusions: Our results indicate that medication adherence is associated with factors other than severity of depression. Work and marital status played a significant role in determining the adherence to antidepressant medications among women.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.